Evidence map›Paper›PMID 37706332›Full record

ArticleHaematologica2024

Oligosecretory Waldenström macroglobulinemia exhibits excellent treatment response and outcomes.

Wenjie Xiong, Ying Yu, Chunyan Sun, Juan Du, Zhen Cai, Zanzan Wang, Xinxin Cao, Yuting Yan, Jiawen Chen, Yanshan Huang and 25 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Wenjie XiongState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin.
Ying YuState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin.
Chunyan SunInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei.
Juan DuDepartment of Hematology, Myeloma Lymphoma Center, Shanghai Changzheng Hospital, The Second Military Medical University, Shanghai.
Zhen CaiBone Marrow Transplantation Center, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou.
Zanzan WangDepartment of Hematology, Ningbo First Hospital, Zhejiang.
Xinxin CaoDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing.
Yuting YanState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin.
Jiawen ChenState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin.
Yanshan HuangState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin.
Zhongxing JiangThe First Affiliated Hospital of Zhengzhou University, Henan.
Huihan WangShengjing Hospital of China Medical University, Liaoning.
Ting NiuWest China Hospital Sichuan University, Chengdu, Sichuan.
Guangzhong YangDepartment of Hematology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing.
Hua XueAffiliated Hospital of Hebei University, Hebei.
Bingzong LiDepartment of Hematology, The second Affiliated Hospital of Soochow University, Suzhou, Jiangsu.
Honghui HuangDepartment of Hematology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai.
Zhenling LiDepartment of Hematology, China-Japan Friendship Hospital, Beijing.
Qinhua LiuDepartment of Hematology, The First Affiliated Hospital of Anhui Medical University, Anhui.
Fei LiThe First Affiliated Hospital of Nanchang University, Jiangxi.
Ou BaiDepartment of Hematology, The First Hospital of Jilin University, Jilin.
Min MaoDepartment of Hematology, Xinjiang Uiger Municipal People's Hospital, Xinjiang.
Rong FuDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin.
Ling WangQingdao Central Hospital, Shandong.
Chunrui LiInstitute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Hubei.
Xiaoxia ChuThe Affiliated Yantai Yuhuangding Hospital of Qingdao University, Shandong.
Lihong LiuDepartment of Hematology, The Fourth Hospital of Hebei Medical University, Hebei.
Yujun DongDepartment of Hematology, Peking University First Hospital, Beijing.
Luqun WangDepartment of Hematology, Qilu Hospital of Shandong University, Shandong.
Jun LuoDepartment of Hematology, The First Affiliated Hospital of Guangxi Medical University, Guangxi.
Yongqiang WeiDepartment of Hematology, Nanfang Hospital, Southern Medical University, Guangdong.
Rui CuiDepartment of Hematology, Tianjin First center hospital, Tianjin.
Lugui QiuState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin.
Jian LiDepartment of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Beijing. lijian@pumch.cn.
Shuhua YiState Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China; Tianjin Institutes of Health Science, Tianjin. yishuhua@ihcams.ac.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Waldenstrom MacroglobulinemiaHumansMutation

Identifiers

PMID37706332
PMCPMC10828770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.